PubMed Journals Articles About "Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease" RSS

21:38 EST 16th January 2019 | BioPortfolio

Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease articles that have been published worldwide.

More Information about "Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease" on BioPortfolio

We have published hundreds of Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease news stories on BioPortfolio along with dozens of Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease Clinical Trials and PubMed Articles about Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease Companies in our database. You can also find out about relevant Atrial Fibrillation Atrial Fibrillation Coronary Atherosclerotic Heart Disease Drugs and Medications on this site too.

Showing "atrial fibrillation atrial fibrillation Coronary Atherosclerotic Heart Disease" PubMed Articles 1–25 of 26,000+

Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure.

Mechanisms of maintenance of both atrial fibrillation and structural left ventricular disease are known to include fibrosis. Galectin-3, a biomarker of fibrosis, is elevated both in patients with heart failure and persistent atrial fibrillation. We sought to find whether galectin-3 has a prognostic value in patients with heart failure and a reduced left ventricular ejection fraction undergoing ablation of persistent atrial fibrillation.

Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.

 Patients with atrial fibrillation (AF) have an increased risk of ischaemic stroke. The risk can be predicted by the CHADS-VASc score, in which the vascular component refers to previous myocardial infarction, peripheral artery disease and aortic plaque, whereas coronary artery disease (CAD) is not included.

Towards a repository of synthetic electrograms for atrial activation detection in atrial fibrillation.

Recently, the analysis of the spatio-temporal behavior of atrial fibrillation activation patterns has been widely investigated with the aim to better understand the arrhythmia implications on the heart electrical activity. Most of the proposed techniques are based on atrial activation timing detections. Unfortunately atrial activation timings are not easily recognizable on the electrograms (EGMs) and an approach to support the validation of such techniques is highly desirable. The aim of this study is to pr...

Valsartan reduced the vulnerability to atrial fibrillation by preventing action potential prolongation and conduction slowing in castrated male mice.

Deficiency of testosterone was associated with the susceptibility of atrial fibrillation. Angiotensin-II receptor antagonists were shown to reduce atrial fibrillation by improving atrial electrical remodeling. This study investigated the effects and mechanism of valsartan, an angiotensin-II receptor antagonist, on the susceptibility to atrial fibrillation with testosterone deficiency.

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.

High monocyte counts are related to adverse outcomes in cardiovascular disease. Their role in prognostication in patients with atrial fibrillation (AF) is unknown. We investigated whether monocyte counts are useful as a marker of prognosis in patients with AF.

Does Left Atrial Appendage Amputation During Routine Cardiac Surgery Reduce Future Atrial Fibrillation and Stroke?

Stroke is the most feared complication of atrial fibrillation. To prevent stroke, left atrial appendage exclusion has been targeted, as it is the prevalent site for formation of heart thrombi during atrial fibrillation. We review the historic development of methods for exclusion of the left atrial appendage and the evidence to support its amputation during routine cardiac surgery.

Disease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort study.

The aim of this study was to study the risk of death and development of arrhythmia and/or subsequently heart failure after an atrial flutter ablation procedure compared with an atrial fibrillation (AF) ablation procedure.

Ablation of atrial fibrillation: Facts for the referring physician.

Radiofrequency ablation has become a safe and effective treatment for atrial fibrillation. We believe that referral to an electrophysiologist for consideration of ablation may allow for better rhythm control and outcomes by altering the natural history of atrial fibrillation progression.

Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry.

Rheumatic heart disease (RHD) is the commonest cause of valvular heart disease and a common cause of heart failure in sub-Saharan Africa (SSA). Atrial fibrillation (AF) complicates RHD, precipitates and worsens heart failure and cause unfavourable outcomes. We set out to describe the prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure (AHF).

Left Ventricular Ejection Fraction Predicts Poststroke Cardiovascular Events and Mortality in Patients without Atrial Fibrillation and Coronary Heart Disease.

It is controversial that decreased left ventricular function could predict poststroke outcomes. The purpose of this study is to elucidate whether left ventricular ejection fraction (LVEF) can predict cardiovascular events and mortality in acute ischemic stroke (AIS) without atrial fibrillation (AF) and coronary heart disease (CHD).

Reply to the letter to the editor: "Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation".

Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.

Atrial fibrillation (AF) and heart failure (HF) frequently coexist and are associated with increased morbidity and mortality risk.

Correlation between atrial fibrillation driver locations and complex fractionated atrial electrograms in patients with persistent atrial fibrillation.

The aim of this study was to evaluate a spatial correlation between active atrial fibrillation (AF) drivers measured by ECGI and complex fractionated atrial electrograms (CFAEs) in patients with persistent AF.

Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation.

Epicardial adipose tissue (EAT) is associated with atrial fibrillation (AF), but the underlying mechanisms remain to be fully elucidated.

Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals.

Paroxysmal atrial fibrillation (PAF) is broadly defined despite high variability in the occurrence and duration of PAF episodes.

The value of syntax score to predict new-onset atrial fibrillation in patients with acute coronary syndrome.

New-onset atrial fibrillation (NOAF) has been associated with poor outcome in patients with acute coronary syndromes (ACS). Also, Syntax score (SS) is a scoring system that is derived from angiographic images and is associated with long-term mortality and major adverse cardiac events. In this study, we aimed to assess the relationship between SS and NOAF with known predictors of atrial fibrillation.

Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation.

Anti-thrombotic management of percutaneous coronary intervention and atrial fibrillation relies on dual antiplatelet therapy and anticoagulation respectively. Because of people ageing, the coexistence of coronary artery disease and atrial fibrillation is increasing. This coexistence raises concerns about the anti-thrombotic strategy, particularly about the association of dual antiplatelet therapy and anticoagulation, known as triple therapy. This triple therapy is responsible for a dramatic increase in blee...

Atrial fibrillation independently linked with depression in community-dwelling older population. Results from the nationwide PolSenior project.

Depression is a frequently observed comorbid condition in patients with cardiovascular diseases. In contrast to coronary heart disease and heart failure there is a limited amount of published data concerning the increased prevalence of depression among patients with atrial fibrillation (AF). Therefore, we decided to assess the prevalence of depression in Polish community-dwelling older patients with a history of AF.

Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications.

Atrial fibrillation increases the risk of stroke by a factor of 4- to 5-fold, and dementia is a common consequence of stroke. However, atrial fibrillation has been associated with cognitive impairment and dementia, even in patients without prior overt stroke. Non-ischemic mechanisms include cerebral hypoperfusion, vascular inflammation, brain atrophy, genetic factors, and shared risk factors such as age or hypertension. Critical appraisal of studies evaluating the association between atrial fibrillation and...

68-year-old woman with paroxysmal atrial fibrillation.

What is the most likely diagnosis?Mitral stenosis.Pericardial cyst.Left atrial appendage aneurysm.Left atrial myxoma.Atrial septal defect.

Effectiveness of a Non-governmental Organization-led Large-scale Community Atrial Fibrillation Screening Program Using Smartphone Electrocardiogram: An Observational Cohort Study.

Opportunistic screening for atrial fibrillation (AF) in patients over 65 years of age is currently recommended.

Safety and Outcomes of Catheter Ablation for Atrial Fibrillation in Adults with Congenital Heart Disease: A Multicenter Registry Study.

An increasing number of adults with congenital heart disease (CHD) are undergoing catheter ablation for atrial fibrillation (AF). Data on ablation strategy and outcomes is limited in CHD. Rhythm control is often felt to be of greater importance among patients with complex CHD.

Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation using the simple ABC (Atrial Fibrillation Better Care) Pathway.

Integrated care for the clinical management of atrial fibrillation patients is advocated as a holistic way to improve outcomes; the simple ABC (Atrial fibrillation Better Care) pathway has been proposed. The ABC pathway streamlines care as follows: 'A' Avoid stroke; 'B' Better symptom management; 'C' Cardiovascular and Comorbidity optimisation.

Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome.

The aim was to determine the association between atrial fibrillation (AF) and outcome in patients undergoing coronary artery bypass grafting (CABG).

Concomitant arrhythmia surgery in patients with congenital heart disease.

Atrial tachyarrhythmia, including atrial fibrillation (AF), atrial flutter (AFL) and intra-atrial reentrant tachycardia (IART), occur frequently in patients with congenital heart disease (CHD), who may undergo multiple surgical procedures throughout life. However, data on the effectiveness of concomitant arrhythmia surgery in CHD patients are scarce.

Quick Search